Filter News
Area of Research
- (-) Nuclear Science and Technology (3)
- Advanced Manufacturing (5)
- Biology and Environment (50)
- Clean Energy (111)
- Climate and Environmental Systems (4)
- Computational Biology (1)
- Computational Engineering (3)
- Computer Science (9)
- Electricity and Smart Grid (1)
- Fusion and Fission (5)
- Fusion Energy (2)
- Isotope Development and Production (1)
- Isotopes (4)
- Materials (74)
- Materials Characterization (1)
- Materials for Computing (14)
- Materials Under Extremes (1)
- Mathematics (1)
- National Security (16)
- Neutron Science (32)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (43)
- Transportation Systems (2)
News Topics
- (-) Biomedical (2)
- (-) Materials Science (1)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (6)
- Bioenergy (1)
- Computer Science (1)
- Decarbonization (1)
- Fusion (2)
- Isotopes (3)
- Molten Salt (3)
- Neutron Science (3)
- Nuclear Energy (17)
- Physics (1)
- Space Exploration (4)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.